How will this affect us all? Is the new WFI Monograph a game changer - an opportunity, or further risk? Hear an expert supplier's point of view...

Our main speaker:
Mr. Paolo Curtó,

graduated in 1984 with Master of Science & PhD in Chemical Engineering at Padua University (Italy). He has worked at DOC since 1997 as Managing Director. In the past he worked in well-known companies like Fidia S.p.a, Foster & Wheeler Group, Enichem S.p.a. He is steering committee member of Parenteral Drug Association (PDA Italy Chapter), an active member of ISPE and international Federation Pharmaceutical (FIP) and qualified trainer for many Regulatory Agencies throughout the world (Brazil, India, China, Italy, Greece etc.)

Agenda
13.00 - 13.30 Registration, The Silken Thomas Suite, Citywest Hotel
13.30 - 14.45 NEW EP Monograph for WFI Production: Regulatory Basis, Technological Challenges and Points to consider from Case Studies, Mr. Paolo Curtó, DOC Managing Director
14.45 - 15.00 Coffee/Tea Break
15.00 - 16.00 Masco Case Study, Mr. M Terraneo, OLSA, and Mr. A Cazzulani, STILMAS
16.00 - 17.00 New EP Monograph: focus on details by Mr. Paolo Curtó, DOC Managing Director
17.00 - 18.00 Group Discussion